Pediatr. praxi. 2012;13(4):230-232

Pediatric viral hepatitis C in the Czech Republic

MUDr.Marek Štefan1, doc.MUDr.Dalibor Sedláček, CSc.2, MUDr.Pavel Dlouhý1
1 Infekční oddělení, Masarykova nemocnice v Ústí nad Labem
2 Infekční klinika, Fakultní nemocnice Plzeň

The article provides basic information on pediatric viral hepatis C in the Czech Republic. Problems with distinguishing between acute

and chronic viral hepatitis C are discussed. Current therapeutic options are described and difficulties in treating injection drug users are

mentioned. The article also includes a case report of an adolescent diagnosed with acute viral hepatitis C.

Keywords: acute hepatitis C, chronic hepatitis C, children, diagnosis, treatment, intravenous drug abuse

Published: August 24, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Štefan M, Sedláček D, Dlouhý P. Pediatric viral hepatitis C in the Czech Republic. Pediatr. praxi. 2012;13(4):230-232.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Husa P. Virové hepatitidy. Praha: Galén 2005: 247.
    2. Vitouš A. Virová hepatitida typu C - diagnostika, terapie, prevence. Interní Med. 2010; 12: 339-342.
    3. Ghany M, et al. AASLD Practice Guidelines. Diagnosis, Management, and Treatment of Hepatitis C: An Update. Hepatology 2009; 49: 1335-1374. Go to original source... Go to PubMed...
    4. Rožnovský L. Virové hepatitidy u dětí a mladistvých a jejich prevence vakcinací. Pediatr. praxi 2007; 8: 228-231.
    5. Kolektiv pracovníků SZÚ. Vybrané infekční nemoci v ČR v letech 2000-2009 - absolutně. Dostupné z: http://www.szu.cz/publikace/data/vybrane-infekcni-nemoci-v-cr-v-letech-1998-2007-absolutne (cit. 14. srpna 2009).
    6. Částková J. SZÚ: VHC v roce 2009 (online). 20. srpna 2010. Osobní komunikace (cit. 20. prosince 2011).
    7. Rožnovský L, et al. Dodatek k protivirové léčbě chronické infekce virem hepatitidy C u dětí a adolescentů. 2008. Dostupné z: http://www.ceska-hepatologie.cz/index.php?node=39 (cit. 20. prosince 2011).
    8. Medscape News. FDA Approves Boceprevir for HCV. Dostupné z: http://www.medscape.org/viewarticle/742766 (cit. 20. února 2012).
    9. Medscape News. FDA Approves Telaprevir for HCV. Dostupné z: http://www.medscape.org/viewarticle/743192 (cit. 20. února 2012).
    10. Hořejší V, Bartůňková J. Základy imunologie. 2. vyd. Praha: Triton 2002: 41-47.
    11. Rozsypal H. Antivirotika. In: Beneš J, a kol. Infekční lékařství. Praha: Galén 2009: 41-44.
    12. Jaeckel E, et al. Treatment of Acute Hepatitis C with Interferon Alfa-2b. The New England Journal of Medicine 2001; 345: 1452-1457. Go to original source... Go to PubMed...
    13. Urbánek P, et al. Standardní diagnostický a terapeutický postup chronické infekce virem hepatitidy C. Časopis lékařů českých 2008; 146: 1-12.
    14. Litwin A, et al. Integrating Services for Injection Drug Users Infected with Hepatitis C Virus with Methadone Maintenance Treatment: Challenges and Opportunities. Clinical Infectious Diseases 2005; 40(Suppl 5): S339-345. Go to original source... Go to PubMed...
    15. Craxi A, et al. EASL Clinical Practice Guidelines: Management of Hepatitis C Virus Infection. Journal of Hepatology 2011; 55: 245-264. Go to original source... Go to PubMed...

    Return to the content


    Pediatrics for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.